title: Cognitive-behavioral therapy for medication-resistant psychosis: a meta-analytic review.
abstract: Patients with schizophrenia often continue to experience disabling positive symptoms, despite adequate trials of medication. In these situations, patients may be prescribed an adjunctive medication, but a more effective choice may be cognitive-behavioral therapy (CBT). This review of 16 published articles from 12 randomized controlled trials found that CBT was associated with robust improvements in the positive symptoms of psychotic disorders. In addition, the improvements were sustained at follow-up, the authors reported.
authors.affiliation: Ms. Burns and Dr. Brenner are with the Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada (e-mail: aburns@psych.ubc.ca. Dr. Erickson is with the Psychology Department, Royal Columbian Hospital, New Westminster, British Columbia. The findings were presented at the annual convention of the Canadian Psychological Association, Quebec City, Quebec, Canada, June 13-15, 2013.
authors.forename: Amy M N
authors.initials: AM
authors.lastname: Burns
authors.affiliation: Ms. Burns and Dr. Brenner are with the Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada (e-mail: aburns@psych.ubc.ca. Dr. Erickson is with the Psychology Department, Royal Columbian Hospital, New Westminster, British Columbia. The findings were presented at the annual convention of the Canadian Psychological Association, Quebec City, Quebec, Canada, June 13-15, 2013.
authors.forename: David H
authors.initials: DH
authors.lastname: Erickson
authors.affiliation: Ms. Burns and Dr. Brenner are with the Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada (e-mail: aburns@psych.ubc.ca. Dr. Erickson is with the Psychology Department, Royal Columbian Hospital, New Westminster, British Columbia. The findings were presented at the annual convention of the Canadian Psychological Association, Quebec City, Quebec, Canada, June 13-15, 2013.
authors.forename: Colleen A
authors.initials: CA
authors.lastname: Brenner
mesh_terms: D015928:Cognitive Behavioral Therapy / Q000379:methods*; D004351:Drug Resistance; D006801:Humans; D011618:Psychotic Disorders / Q000628:therapy*